SciELO - Scientific Electronic Library Online

 
vol.37 issue2Acquisition mode pesticides and drugs in intoxicated patients treated in emergency Hospital Clínico ViedmaClinical and laboratory characteristics of HIV-AIDS and meningeal cryptococcosis coinfection in the Hospital ClínicoViedma in Cochabamba, Bolivia author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Gaceta Médica Boliviana

Print version ISSN 1012-2966On-line version ISSN 2227-3662

Abstract

TORRICO GUILLEN, Daniela; CLAROS ESPINOZA, Karen  and  VALDEZ GUZMAN, Bethzi. Sequential therapy for Helicobacter pylori eradication: ¿superior to triple standard therapy?. Gac Med Bol [online]. 2014, vol.37, n.2, pp.60-63. ISSN 1012-2966.

Objectives: to establish the efficacy of sequential therapy as primary treatment for the eradication of Helicobacter pylori compared with standard triple therapy. Methods: prospective, randomized, open, based on population study, including patients older than 15 years attending outpatient Gastroenterology Department on Hospital Obrero Nro. 2 (Cochabamba, Bolivia) from june to december 2013. Study has two arms: standard triple therapy (Omeprazole, Clarithromycin, Amoxicillin for 10 days) and sequential therapy (Omeprazole and Amoxicillin for 5 days followed by Omeprazole, Clarithromycin and Tinidazole for 5 days). Results: we included 200 patients in the study. There was a clear predominance of females and more than 40 years among the affected age. The eradication rate was 36% in the standard therapy group and 80% in the sequential therapy (p <0.001), with an absolute difference of 44% for sequential therapy. Conclusions: the sequential therapy was superior to standard triple therapy for the eradication of Helicobacter pylori.

Keywords : Helicobacter pylori; antibacterial agents; sequential therapy.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License